Anti-rejection drug may increase risk of diabetes after kidney transplant
Thursday, May 22, 2008 - 13:21
in Health & Medicine
For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a study in the July Journal of the American Society of Nephrology (JASN).